Deletion of Ramesh Pandey (CEO)

Comment: per K.e.coffman and . There is no evidence of independent notability
Stance: delete
Cited policy: Wikipedia:Arguments to avoid in deletion discussions (WP:NOTINHERITED)

Comment: does not meet . "Oppose" a redirect to the drug (Nicosan) -- not a suitable target. A better target would have been his company, but it's nn itself. In any case, I'm not a fan of BLP redirects to a company. The drug name would be even less suitable
Stance: delete
Cited policy: Wikipedia:Notability (WP:ANYBIO)